Last reviewed · How we verify

NCT05895669: COLT

Cardiovascular Outcomes in Orthotopic Liver Transplanted Patients (COLT Study)

Status unknown Last updated 8 June 2023
What this trial tests

trial in Liver Transplant; Complications in 100 participants. Status unknown.

Timeline
2 May 2023
Primary endpoint
2 May 2024
2 May 2024

Quick facts

Lead sponsorUniversity of Campania Luigi Vanvitelli
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date2 May 2023
Primary completion2 May 2024
Estimated completion2 May 2024
Sites2 locations across Italy

Conditions studied

Sponsor

University of Campania Luigi Vanvitelli

Who can join

18 and older, any sex, with Liver Transplant; Complications or Cardiovascular Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

All patients with orthotopic liver transplantation who are evaluated and followed at each participating centers will be recorded in this study. Within this register a characterization of patients and therapy will be done. Prognostic factors of defined clinical relevant endpoints will be evaluated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study.
    Caturano A, Albanese G, Di Martino A, Coppola C, et al · · 2023 · cited 3× · PMID 37893240 · DOI 10.3390/biomedicines11102866

Verify or expand the search:

Other recruiting trials for Liver Transplant; Complications

Currently open trials in the same condition.

Other University of Campania Luigi Vanvitelli trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05895669.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing